IMP4297(20mg)

DRUG2 trials

Sponsors

Impact Therapeutics, Inc.

Conditions

Solid Tumor

Phase 1

An BE Study to Compare 10mg & 20mg of IMP4297 Capsules in Healthy Chinese Subjects Under Fed Condition

CompletedNCT05391048

Impact Therapeutics, Inc.Solid Tumor

Start: 2022-06-06End: 2022-07-21Updated: 2025-09-16

An BE Study to Compare 10mg & 20mg of IMP4297 Capsules in Healthy Chinese Subjects Under Fasting Condition

CompletedNCT05390944

Impact Therapeutics, Inc.Solid Tumor

Start: 2022-06-08End: 2022-08-01Updated: 2025-09-16